Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy

Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy

Luca Prosperini,1 Lorenzo Pradelli,2 Laura Santoni,3 Daria Perini,3 Salvatore Cottone,4 Marco Vercellino5 1S. Camillo-Forlanini Hospital, Rome, Italy; 2AdRes Health Economics and Outcomes Resources, Turin, Italy; 3Biogen Italia, Milan, Italy; 4Department of Neurology, A.R.N.A.S. Civico, Palermo, Ita...

Full description

Saved in:
Bibliographic Details
Main Authors: Prosperini L, Pradelli L, Santoni L, Perini D, Cottone S, Vercellino M
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
intravenous natalizumab
subcutaneous natalizumab
multiple sclerosis
ms center
patient perspective
society perspective
Online Access:https://www.dovepress.com/cost-minimization-analysis-and-budget-impact-analysis-about-subcutaneo-peer-reviewed-fulltext-article-CEOR
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items